Additional Information

Utilizing metabolism-centered CRISPR screens, we aim to understand how genomic stability controls redox metabolism in aggressive solid tumors. Our research centered on identify genetic determinants of DNA damage response (DDR) inhibitors resistance in non-small cell lung cancers.